Press Releases

AKRON, Ohio, Dec. 12, 2019 /PRNewswire/ -- The holiday season is upon us! This time of year is meant to be spent with friends and family, celebrating the end of another year. But as it's also flu season, and with the latest Centers for Disease Control and Prevention (CDC) report showing regional or widespread activity in half the country, 1 we also w

LAS VEGAS, Dec. 12, 2019 /PRNewswire/ -- Celebrating their first birthday today, twin brothers Andrew and Isaac Brincat of Sterling Heights, Michigan, have already faced more medical challenges than most will in a lifetime. The infant boys were born with clubfoot, a complex condition that causes their t

SUNNYVALE, Calif., Dec. 12, 2019 /PRNewswire/ -- Timpanogos Cancer Services made history in Utah recently with the installation of the state's first

NEW YORK, Dec. 12, 2019 /PRNewswire/ -- Sproutt Insurance, the next evolution of life insurance, announced today that it has launched and secured $12 million in

GARDENA, Calif., Dec. 12, 2019 /PRNewswire/ -- In their recently released Christmas-inspired blog,

CARLSBAD, Calif., Dec. 12, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) ("Ionis") announced today that it has entered into privately negotiated exchange and/or subscription agreements, with certain holders of its outstanding 1.00% Convertible Senior Notes due 2021 (the "2021 Notes") and certain new investors pursuant to which Ionis will issue

MENLO PARK, Calif., Dec. 12, 2019 /PRNewswire/ -- Entering into a new decade, boards and C-suite leaders around the globe are concerned with the escalating competition for specialized talent, their organizations' culture and the ability to advance their digital maturity and embrace the transformative opportunities of technology. According to a new survey from Protiv

EUGENE, Ore., Dec. 12, 2019 /PRNewswire/ -- Good Clean Love, the renowned natural personal care products company, has launched a first-of-its-kind resource for Women's Health. The

PRINCETON, N.J., Dec. 12, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has opened the study titled "A Phase 1C, Double-Blind, Placebo-Controlled, Randomized S

Canopy Growth's first line of CBD products are available for purchase through e-commerce platform available at